Skip to search.
 All Ordinaries Up0.98%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS

7.92 19 Jun 06:00

Add to Portfolio
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):3.2
Mean Recommendation (last week):3.2
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:6.92
Median Target:7.00
High Target:8.50
Low Target:6.00
No. of Brokers:6

Data provided by Thomson/First Call
Upgrades & Downgrades History
DateResearch FirmActionFromTo
20/01/2011RBC Capital MktsUpgradeSector PerformOutperform
10/09/2010RBC Capital MktsInitiated Sector Perform
27/03/2009Lazard Capital MktsUpgradeHoldBuy
05/01/2009JP MorganUpgradeUnderweightNeutral
11/09/2008JP MorganDowngradeNeutralUnderweight
13/06/2008Credit SuisseDowngradeOutperformNeutral
22/04/2008WachoviaDowngradeOutperformMkt Perform
10/03/2008Susquehanna FinancialDowngradePositiveNeutral
05/03/2008Lehman BrothersDowngradeOverweightEqual-weight
05/03/2008Broadpoint CapitalDowngradeBuyNeutral
Data provided by Briefing.com

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy0000
Buy0000
Hold5444
Underperform1111
Sell0000

Data provided by Thomson/First Call


Currency in USD.